Coronavirus – Impact on Valuing Venture Capital Investments at March 31, 2020 Webcast Replay

or to bookmark this page

Click here to bookmark this page

Click here to remove bookmark

Coronavirus – Impact on Valuing Venture Capital Investments at March 31, 2020

The Covid-19 pandemic is impacting the global population and economy in unprecedented ways. As venture capital fund managers and corporate investors in non-traded or infrequently traded debt and equity investments exercise their fiduciary duty to report independent and credible fair value information to investors and stakeholders, significant informed judgement will be required. Government actions taken in response to the rapidly changing global health situation due to COVID-19, combined with public market volatility and the potential for a global recession make the judgments reached with respect to fair value at March 31, 2020 very difficult. Response to the crisis from a fair value perspective requires reasoned informed judgment to provide investors, stakeholders, and beneficiaries with decision useful information. Further, the current environment raises questions with respect to applying ASU 2016-01 for corporate venture investors.

Watch our webcast replay around how to reflect the impact of COVID-19 and current market conditions when estimating and reporting the fair value of early stage investments for the March 31, 2020 quarter end.

Originally presented on April 8, 2020.

 

Download webcast slides.

Duration: 75 minutes

Topics

  • Can the price of a financing round that occurred pre-crisis be used to estimate fair value at March 31, 2020?
  • How is the fair value of venture capital investments impacted by the pandemic and market volatility?
  • How should actual portfolio company results for Q1 2020 impact fair value estimates at March 31, 2020?
  • How should projected investee company value drivers impacted by the pandemic be reflected in estimating fair value (revenue, cost, growth, competition, market conditions, etc.)?
  • Should projections be updated and what is the impact on fair value if they have not been updated?
  • Applying ASU 2016-01 when measuring corporate investments at March 31, 2020
  • Practical case studies focused on key fair value questions.
  • What questions will LPs be asking with respect to March 31, 2020 fair value estimates?

Presenters

To avail CPE credit, please visit our CPE On Demand page.

2020-04-16T00:00:00.0000000 /insights/webcasts-and-videos/webcast-replay-coronavirus-impact-valuing-venture-capital-investments webcast {B062D54C-1425-4A04-8F9F-95EA14068E6D} {65648E61-ED08-40DF-AEE6-DB90ABD49289} {5BF06FE7-E88C-4627-A701-3E042F076F1F}

Contact Us

Other Areas We Can Help

Valuation Advisory

Valuation Advisory

Valuation and consulting for financial reporting, federal, state and local tax, investment and risk management purposes.

Valuation Advisory
Transfer Pricing

Portfolio Valuation

Alternative investment valuation for private equity and hedge funds.

Portfolio Valuation
Transfer Pricing

Alternative Asset Advisory

Provides an array of consulting services to alternative investment managers and investors.

Alternative Asset Advisory

Insights

Transfer Pricing

Asia's Response to the COVID-19 Impact – Transfer Pricing Documentation, Benchmarking and APAs

Transfer Pricing
Transfer Pricing

Transfer Pricing Times – Third Quarter 2020

Transfer Pricing
Transfer Pricing

Non-Resident Taxation of German Registered IP Rights

Transfer Pricing